Logo
 Home | Sitemap | Contact us | Search | Language
Left Right
Home >> Industrial and Microbial Biotechnology >> Protein and Enzymes Engineering >>Gene Modification Through Oligonucleotide Synthesis

Gene Modification Through Oligonucleotide Synthesis
Since oligonucleotides can be synthesized using automatic DNA synthesizers with solid supports, gene modification has become much easier. There are two general methods of gene modification using synthetic oligonucleotides.

(a) In vitro mutagenesis using synthetic oligonucleotides as PCR primers
Synthetic oligonucleotides can be used for in vitro mutagenesis of genes of interest. In this method, a small synthetic oligonucleotide primer containing the desired modification is first synthesized. The modified oligonucleotide primer is then used for PCR amplification of cloned gene so that the rest of the gene remains unaltered.
The above approach was actually utilized to modify the active site of tyrosyl-rRNA synthetase, whose crystal structure was known. In this enzyme, at position 35, cystein was replaced by serine with the predicted effect of lowering Km for adenosine triphosphate. In 1983, this was described as a major step forward in protein engineering. Polymerase chain reaction (PCR) can also be used for introducing mutations in known genes for the purpose of protein engineering.

(b) Altered oligonucleotide to be ligated
As we know, complete genes in some cases have been chemically synthesized in the form of several oligomers (e.g. genes for insulin, somatostatin and interferon) that were ligated in the correct order to produce a complete gene. The sequence of the synthetic gene can be designed in a modular fashion so that it may have sites for restriction enzymes at convenient positions.
By convenient positions we mean that subsequently the gene can be cleaved at these sites giving fragments, in which modifications may be introduced leading to alteration in function. Since a number of oligomers are involved, modifications can be introduced in different oligomers and these modified oligomers can be used in ligation mixture for synthesis of complete gene, which will have several desired modifications.
This method can be used for making extensive changes in the amino acid sequence of the protein. This can be illustrated by using the example of interferon gene, which was artificially synthesized. It was possible to modify portions of the interior of this artificially synthesized gene, so that a variety of artificial interferon genes could be prepared. These genes were found to express in E. coli.

Although, significant results as above have been obtained from redesigning of natural biocatalysts, changes in amino acid residues, as above, provide only chemical diversity, and can not allow the designing of new biocatalysts. Following are the limitatations of this approach. (i) Enzyme engineering demands development of new features that are not available in nature, since they did not confer any evolutionary advantage. (ii) Many biocatalyst properties are dependent on many amino acid residues distributed over large parts of the protein. (iii) Most sequence changes, accumulated during evolution, have little or no effect on the property of interest. For instance, stability of enzyme depends on hundreds of amino acids and their complex interactions, so that no rules for enhancing stability were available from sequence comparisons. However, stability has been a good target for protein modeling through computational methods.

Despite the limitations of the above approach, nearly all engineered enzymes came from structure-based protein engineering done in 1980s. Although the successes were notable, but results were costly and came slowly. Although some properties like specificity can be altered as above, this approach is not suitable for developing new biocatalysts, for which evolutionary protein design methods are used, which are described in the next section.

 

Left Right